Mankind Pharma announced the pledge of nearly 40 per cent of its wholly-owned subsidiary, Bharat Serums and Vaccines Limited, ...

Nuvectis Pharma shares fell steeply after updated data from its early-stage study evaluating NXP800 to treat an aggressive type of ovarian cancer showed that a change in the dosing schedule only ...

JB Pharma, Sun, Torrent ,Lupin, Abbott, Glenmark, Dr Reddy’s Cipla, Zydus remained among Key pharma market growth drivers in ...

Rekha Rakesh Jhunjhunwala, through multiple discretionary trusts, owned 25,199,240 equity shares, or 24.09 per cent stake in ...

Eli Lilly (NYSE: LLY) sells a broad range of pharmaceuticals treating various diseases, but one portfolio in particular has ...

Sudarshan Pharma Industries has proposed a stock split, reducing the face value of each share from Rs 10 to Rs 1, with each ...

United Therapeutics' pipeline and Tyvaso DPI drive strong growth. Read why UTHR stock offers substantial upside with ...

Amidst October's volatile stock market and a dip in the Nifty, Indian fund managers focused on long-term growth sectors. They ...

Some Bayer investors say CEO Bill Anderson should speed up turnaround efforts, including boosting efficiency and drug ...

The 30-share BSE Sensex pack fell 111 points or 0.14 per cent to close at 77,580 and the broader NSE barometer Nifty hit ...

It attributed the downturn to the July-August mass upsurge, labour unrest, and prolonged flooding, which significantly impacted operations and distribution channels.

Glenmark Pharmaceuticals reported a second-quarter profit on Thursday, helped by strong demand for its drugs that treat long-term illnesses. The drugmaker reported a consolidated profit of ...